AMRC vs HLMN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits weak financial health with a Piotroski F-Score of just 2/9, indicating significant fundamental deterioration. Despite recent earnings surprises and positive short-term growth momentum, high leverage (Debt/Equity of 2.25), low profitability margins, and a lack of Altman Z-Score due to potential distress risk raise serious concerns. The stock trades well above its Graham Number of $23.05 and intrinsic value of $19.06, implying overvaluation relative to defensive and growth-based metrics. Bearish insider activity and inconsistent earnings performance further undermine confidence in a sustainable turnaround.
HLMN presents a conflicted profile with a stable Piotroski F-Score of 4/9 and a strong current ratio, yet it trades at a significant premium to its Graham Number ($5.30) and Intrinsic Value ($1.40). While the current P/E of 44.05 is high, the Forward P/E of 12.47 suggests a strong expectation of earnings growth that analysts are pricing in. However, thin profit margins (2.60%) and bearish insider sentiment offset the bullish analyst consensus. The stock is currently a speculative play on earnings recovery rather than a value investment.
Compare Another Pair
Related Comparisons
AMRC vs HLMN: Head-to-Head Comparison
This page compares Ameresco, Inc. (AMRC) and Hillman Solutions Corp. (HLMN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.